|
YLPM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81765713591631E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.55190346421364E-11 |
| Normal-vs-Stage2 |
2.11479999999709E-05 |
| Normal-vs-Stage3 |
1.98749905422346E-11 |
| Normal-vs-Stage4 |
5.68449731730425E-11 |
| Stage1-vs-Stage2 |
5.310600E-01 |
| Stage1-vs-Stage3 |
2.255200E-01 |
| Stage1-vs-Stage4 |
3.993600E-02 |
| Stage2-vs-Stage3 |
1.562250E-01 |
| Stage2-vs-Stage4 |
5.422300E-02 |
| Stage3-vs-Stage4 |
4.374400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84841031369842E-12 |
| Normal-vs-AfricanAmerican |
2.859300E-03 |
| Normal-vs-Asian |
3.63449999984944E-07 |
| Caucasian-vs-AfricanAmerican |
1.469950E-01 |
| Caucasian-vs-Asian |
8.780200E-01 |
| AfricanAmerican-vs-Asian |
2.317200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9293902293357E-14 |
| Normal-vs-Female |
3.33399974294935E-11 |
| Male-vs-Female |
4.399700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.4714995888454E-10 |
| Normal-vs-Age(41-60Yrs) |
2.45049980307499E-10 |
| Normal-vs-Age(61-80Yrs) |
9.96359661442625E-11 |
| Normal-vs-Age(81-100Yrs) |
8.045300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.928600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.673200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.639000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.347800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.512800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.311800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.687890E-02 |
| Classical-VS-Follicular |
1.888480E-02 |
| Classical-VS-Other |
5.125900E-02 |
| Classical-VS-Normal |
1.74919967399489E-10 |
| Tall-VS-Follicular |
5.319800E-01 |
| Tall-VS-Other |
4.184200E-01 |
| Tall-VS-Normal |
7.02540026153997E-10 |
| Follicular-VS-Other |
3.770000E-01 |
| Follicular-VS-Normal |
6.37879971066013E-10 |
| Other-VS-Normal |
1.960260E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.1713968924646E-11 |
| Normal-vs-N1 |
3.88170051657255E-10 |
| N0-vs-N1 |
1.081800E-01 |
|
|
